CSTL: Castle Biosciences, Inc.
Performance
CSTL +4.06%
Watchlist
Select an item
Summary
CSTL at a glance
CSTL returned +4.06% over the past year and -10.38% a year over five years. Its worst drop in that year was -57.83%, smaller than 14% of stocks on Redstone, and its Sharpe ratio of 0.28 beats 40% of stocks on Redstone. It pays no dividends.
Current Drawdown
-20.12%
Rolling Volatility
59.80%
Actions
Metrics
Risk Indicators
Alpha3.87%
Beta1.16x
Sharpe0.28
Sortino0.38
Omega1.05
Calmar0.07
Martin0.47
Profile
About CSTL
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $1.1B
- Listed
- Jul 2019
- Employees
- 1,002
- Headquarters
- Friendswood, TX
- Website
- castlebiosciences.com
Comparisons